Drugs / AG200-15
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01422135 | Feb → Apr 2011 | — | Agile Therapeutics | Completed | No outcome recorded |
| Phase 1 | NCT01243580 | Aug → Dec 2009 | — | Agile Therapeutics | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01236768 | Oct 2010 → Jun 2011 | — | Agile Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AG200-15 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01236768 ↗ |
| Route | Other | “Thin transdermal contraceptive delivery system (TCDS)” NCT01236768 ↗ |